Panminerva Medica 2024 Feb 27

DOI: 10.23736/S0031-0808.24.05064-X

lingua: Inglese

Efficacy and safety evaluation of Venetoclax combined with homoharringtonine regimen in the treatment of patients with refractory and relapsed acute myeloid leukemia

Mingxia WEI ¹ ✉, Xuliang SHEN ¹, Chunyan ZHAI ¹, Wenyu GAO ²

¹ Department of Hematology, Heping Hospital Affiliated to Changzhi Medical College, Shanxi, China; ² Department of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China

PDF Materiale_Supplementare

inizio pagina

I TUOI DATI

I TUOI ORDINI

CESTINO ACQUISTI

COME ORDINARE

I TUOI ABBONAMENTI

I TUOI ARTICOLI

I TUOI EBOOK

COUPON

ACCESSIBILITÀ

Panminerva Medica 2024 Feb 27

Efficacy and safety evaluation of Venetoclax combined with homoharringtonine regimen in the treatment of patients with refractory and relapsed acute myeloid leukemia

Publication History

Per citare questo articolo

Corresponding author e-mail

Share